Compagnie Lombard Odier S Cm A Regeneron Pharmaceuticals, Inc. Transaction History

Compagnie Lombard Odier S Cm A

  • $6.12 Billion
  • Q3 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 450 shares of REGN stock, worth $340,564. This represents 0.01% of its overall portfolio holdings.

Number of Shares
450
Previous 450 -0.0%
Holding current value
$340,564
Previous $472,000 0.21%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024
SELL
$883.2 - $1071.19 $172,224 - $208,882
-195 Reduced 30.23%
450 $472,000
Q1 2024

May 01, 2024
SELL
$902.69 - $993.35 $40,621 - $44,700
-45 Reduced 6.52%
645 $620,000
Q3 2023

Oct 23, 2023
SELL
$692.45 - $844.37 $754,770 - $920,363
-1,090 Reduced 61.24%
690 $567,000
Q1 2023

May 01, 2023
SELL
$680.49 - $826.97 $68,049 - $82,697
-100 Reduced 5.32%
1,780 $1.46 Million
Q3 2021

Oct 28, 2021
BUY
$574.03 - $680.96 $464,964 - $551,577
810 Added 75.7%
1,880 $1.14 Million
Q2 2021

Jul 15, 2021
SELL
$472.8 - $558.54 $49,644 - $58,646
-105 Reduced 8.94%
1,070 $598,000
Q1 2021

Apr 23, 2021
SELL
$446.73 - $548.2 $78,177 - $95,935
-175 Reduced 12.96%
1,175 $556,000
Q4 2020

Feb 09, 2021
BUY
$478.3 - $607.98 $38,264 - $48,638
80 Added 6.3%
1,350 $652,000
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $152,530 - $184,298
280 Added 28.28%
1,270 $711,000
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $93,730 - $122,344
-190 Reduced 16.1%
990 $617,000
Q1 2020

May 13, 2020
BUY
$336.18 - $494.43 $127,748 - $187,883
380 Added 47.5%
1,180 $576,000
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $27,687 - $38,027
-101 Reduced 11.21%
800 $300,000
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $82,989 - $114,905
-277 Reduced 23.51%
901 $282,000
Q1 2019

May 13, 2019
SELL
$372.08 - $439.57 $111,624 - $131,871
-300 Reduced 20.3%
1,178 $483,000
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $26,193 - $31,437
78 Added 5.57%
1,478 $552,000
Q2 2018

Aug 10, 2018
SELL
$284.6 - $344.99 $17,076 - $20,699
-60 Reduced 4.11%
1,400 $483,000
Q1 2018

May 11, 2018
SELL
$315.82 - $393.78 $10,422 - $12,994
-33 Reduced 2.21%
1,460 $503,000
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $535,434 - $701,635
1,493
1,493 $561,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email